COM:LARIMARTX
Larimar Therapeutics
- Stock
Last Close
9.04
13/11 21:00
Market Cap
584.11M
Beta: -
Volume Today
943.29K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 35.53M - | 73.81M 107.74% | 58.23M 21.12% | 53.00M 8.98% | 61.12M 15.33% | 23.21M 62.02% | 42.80M 84.39% | 50.47M 17.90% | 36.53M 27.62% | 41.76M 14.32% | |
cost of revenue | 311K - | ||||||||||
depreciation and amortization | 70K - | 212K 202.86% | 188K 11.32% | 261K 38.83% | 78K 70.11% | 155K 98.72% | 326K 110.32% | 318K 2.45% | 311K 2.20% | ||
ebitda | -35.53M - | -74.69M 110.20% | -57.32M 23.26% | -50.87M 11.25% | -61.35M 20.61% | -23.14M 62.29% | -42.80M 85.01% | -50.47M 17.90% | -36.53M 27.62% | -41.45M 13.47% | |
eps | -0.00 - | -33.32 1,110,566.67% | -25.44 23.65% | -22.76 10.53% | -22.85 0.40% | -2.51 89.02% | -3.56 41.83% | -2.93 17.70% | -1.33 54.61% | -0.84 36.84% | |
eps diluted | -0.00 - | -33.32 1,110,566.67% | -25.44 23.65% | -22.76 10.53% | -22.85 0.40% | -2.51 89.02% | -3.56 41.83% | -2.93 17.70% | -1.33 54.61% | -0.84 36.84% | |
general and administrative expenses | 8.14M - | 19.20M 135.78% | 18.29M 4.72% | 12.16M 33.51% | 13.19M 8.50% | 2.42M 81.63% | 11.40M 370.17% | 12.07M 5.90% | 12.28M 1.72% | ||
gross profit | -311K - | ||||||||||
income before tax | -36.57M - | -74.29M 103.13% | -57.88M 22.09% | -52.03M 10.11% | -61.37M 17.95% | -23.13M 62.31% | -42.48M 83.65% | -50.64M 19.19% | -35.35M 30.18% | -36.95M 4.51% | |
income tax expense | -946K - | 694K 173.36% | 1.94M 179.83% | -492K 125.33% | -155K - | -326K 110.32% | -1.17M 259.20% | ||||
interest expense | -870K - | -473K 45.63% | 347K 173.36% | 971K 179.83% | -246K 125.33% | -1.77M 617.89% | -318K - | ||||
interest income | 28K - | 438K 1,464.29% | 894K 104.11% | 996K 11.41% | 1.89M 89.66% | 1.99M 5.29% | |||||
net income | -36.57M - | -74.29M 103.13% | -57.88M 22.09% | -52.03M 10.11% | -61.37M 17.95% | -23.13M 62.31% | -42.33M 82.98% | -50.31M 18.86% | -34.18M 32.05% | -36.95M 8.09% | |
operating expenses | 35.53M - | 73.81M 107.74% | 58.23M 21.12% | 53.00M 8.98% | 61.12M 15.33% | 23.21M 62.02% | 42.80M 84.39% | 50.47M 17.90% | 36.53M 27.62% | 41.45M 13.47% | |
operating income | -35.53M - | -73.81M 107.74% | -58.23M 21.12% | -53.00M 8.98% | -61.12M 15.33% | -23.21M 62.02% | -42.80M 84.39% | -50.47M 17.90% | -36.53M 27.62% | -41.76M 14.32% | |
other expenses | 82K - | 322K 292.68% | -171K 153.11% | 1.17M 784.80% | |||||||
research and development expenses | 27.39M - | 54.62M 99.40% | 39.94M 26.88% | 40.84M 2.26% | 47.93M 17.36% | 20.79M 56.62% | 31.41M 51.07% | 38.40M 22.25% | 24.25M 36.84% | 27.36M 12.82% | |
revenue | |||||||||||
selling and marketing expenses | |||||||||||
selling general and administrative expenses | 8.14M - | 19.20M 135.78% | 18.29M 4.72% | 12.16M 33.51% | 13.19M 8.50% | 2.42M 81.63% | 11.40M 370.17% | 12.07M 5.90% | 12.28M 1.72% | 14.09M 14.76% | |
total other income expenses net | -1.04M - | -473K 54.43% | 347K 173.36% | 971K 179.83% | -246K 125.33% | 82K 133.33% | 322K 292.68% | -171K 153.11% | 1.17M 784.80% | 4.81M 310.67% | |
weighted average shs out | 12.19B - | 2.23M 99.98% | 2.27M 2.03% | 2.29M 0.50% | 2.69M 17.48% | 9.21M 243.08% | 11.88M 28.97% | 17.16M 44.44% | 25.76M 50.09% | 43.90M 70.41% | |
weighted average shs out dil | 12.19B - | 2.23M 99.98% | 2.27M 2.03% | 2.29M 0.50% | 2.69M 17.48% | 9.21M 243.08% | 11.88M 28.97% | 17.16M 44.44% | 25.76M 50.09% | 43.90M 70.41% |
All numbers in (except ratios and percentages)